Mesa Laboratories Cash Flow Statement
NASDAQ: MLABIndustrialsIndustrial Machinery/ComponentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Mesa Laboratories free cash flow
In fiscal 2026, Mesa Laboratories generated $42.8 million of operating cash flow and spent $3.3 million on capital expenditures. That left free cash flow of $39.6 million, a free-cash-flow margin of 15.9% of revenue. Free cash flow was down 7.0% from the prior year's $42.6 million.
Mesa Laboratories returned $3.5 million to shareholders through dividends, equal to 9% of free cash flow. Free cash flow covered dividend payments 11.2 times.
Summary generated from market data by MetaCap's automated system. Methodology
Mesa Laboratories cash flow statement (annual)
| Fiscal year (USD) | FY 20262026-03-31 | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 | FY 20192019-03-31 | FY 20182018-03-31 | FY 20172017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 6.71M | -1.97M | -254.25M | 930.00K | 1.87M | 3.27M | 1.78M | 7.48M | -2.96M | 11.18M |
| Net Income growth (YoY) | — | — | -27438.28% | -50.29% | -42.85% | +84.14% | -76.24% | — | -126.49% | +0.13% |
| Depreciation & Amortization | 5.25M | 5.38M | 4.23M | 33.82M | 25.07M | 17.66M | 12.99M | 9.43M | 9.47M | 8.74M |
| Stock-Based Compensation | 17.87M | 13.14M | 11.94M | 12.54M | 11.39M | 9.27M | 5.53M | 4.21M | 1.67M | 1.41M |
| Change in Working Capital | -5.59M | 6.41M | 5.76M | -16.60M | -3.59M | 2.37M | -2.71M | 10.79M | 3.39M | -2.85M |
| Operating Cash Flow | 42.83M | 46.81M | 44.13M | 27.98M | 39.22M | 37.07M | 26.99M | 30.55M | 25.72M | 17.30M |
| Capital Expenditures | -3.25M | -4.25M | -2.57M | -4.54M | -4.43M | -1.99M | -1.50M | -1.26M | -2.80M | — |
| Investing Cash Flow | -3.25M | -4.50M | -81.31M | -9.49M | -305.23M | -1.99M | -185.59M | -3.88M | -17.18M | -18.41M |
| Dividends Paid | -3.52M | -3.47M | -3.45M | -3.41M | -3.34M | -3.17M | -2.72M | -2.46M | -2.41M | -2.35M |
| Debt Repaid | -36.75M | -44.25M | -33.50M | -36.00M | -21.00M | 0 | -23.00M | -25.63M | -19.63M | -57.00M |
| Financing Cash Flow | -41.85M | -44.51M | 32.84M | -33.33M | 52.58M | 146.23M | 231.28M | -21.67M | -9.02M | 1.15M |
| Net Change in Cash | -393.00K | -893.00K | -4.70M | -16.44M | -214.52M | 182.49M | 71.19M | 4.72M | -351.00K | 125.00K |
| Free Cash Flow | 39.58M | 42.56M | 41.57M | 23.44M | 34.79M | 35.08M | 25.49M | 29.29M | 22.92M | 17.30M |
This table shows 10 annual periods of Mesa Laboratories's cash flow statement, from FY 2026 back to FY 2017, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MLAB's reporting calendar. What is a cash flow statement?